当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析 - 现金流量表

安科生物

(300009)

  

流通市值:123.03亿  总市值:168.42亿
流通股本:12.22亿   总股本:16.73亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,260,699,934.56583,728,044.362,452,332,687.931,852,782,829.47
  收到其他与经营活动有关的现金18,024,534.839,454,540.0352,883,663.0223,206,682.8
  经营活动现金流入小计1,278,724,469.39593,182,584.392,505,216,350.951,875,989,512.27
  购买商品、接受劳务支付的现金167,714,074.274,002,187.9244,164,943.72245,793,981.54
  支付给职工以及为职工支付的现金279,157,334.19105,926,634.65606,093,180.3510,246,479.25
  支付的各项税费140,098,177.151,874,478.18223,785,041.13178,803,195.09
  支付其他与经营活动有关的现金375,330,049.59166,150,306.76745,801,238.71520,241,367.21
  经营活动现金流出小计962,299,635.08397,953,607.491,819,844,403.861,455,085,023.09
  经营活动产生的现金流量净额316,424,834.31195,228,976.9685,371,947.09420,904,489.18
二、投资活动产生的现金流量:
  收回投资收到的现金967,304,820.53976,416,335.241,222,631,5001,115,797,001
  取得投资收益收到的现金12,040,010.456,645,145.9933,712,137.8528,529,057.66
  处置固定资产、无形资产和其他长期资产收回的现金净额385,905.68245,490.05894,578.08999,421.34
  处置子公司及其他营业单位收到的现金净额0--10,100,000
  收到的其他与投资活动有关的现金2,380,232.05919,845.284,985,499.525,100,856.56
  投资活动现金流入小计982,110,968.71984,226,816.561,262,223,715.451,160,526,336.56
  购建固定资产、无形资产和其他长期资产支付的现金32,753,045.6321,265,986.47117,223,979.9199,811,727.26
  投资支付的现金768,905,236.21987,008,702.941,314,047,731.94921,136,905.28
  取得子公司及其他营业单位支付的现金--1,199,616.6723,654,929.13
  投资活动现金流出小计801,658,281.841,008,274,689.411,432,471,328.521,044,603,561.67
  投资活动产生的现金流量净额180,452,686.87-24,047,872.85-170,247,613.07115,922,774.89
三、筹资活动产生的现金流量:
  取得借款收到的现金7,000,000-5,000,0005,000,000
  收到其他与筹资活动有关的现金11,313,750---
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计18,313,750-5,000,0005,000,000
  偿还债务支付的现金5,000,000---
  分配股利、利润或偿付利息支付的现金418,065,411.16165,333,622.2418,044,713.66413,430,874.5
  其中:子公司支付给少数股东的股利、利润4,680,460-2,471,8202,471,820
  支付其他与筹资活动有关的现金60,355,491.7541,207,094.3762,335,037.0736,446,075.65
  筹资活动现金流出小计483,420,902.91206,540,716.57480,379,750.73449,876,950.15
  筹资活动产生的现金流量净额-465,107,152.91-206,540,716.57-475,379,750.73-444,876,950.15
四、汇率变动对现金及现金等价物的影响-2,908,775.77-2,470,049.3376,401.9447,093.95
五、现金及现金等价物净增加额28,861,592.5-37,829,661.8539,820,985.2391,997,407.87
  加:期初现金及现金等价物余额298,604,934.97298,604,934.97258,783,949.74258,783,949.74
  期末现金及现金等价物余额327,466,527.47260,775,273.12298,604,934.97350,781,357.61
补充资料:
  净利润374,553,615.38-715,837,906.16-
  资产减值准备3,099,669.73-16,815,268.43-
  固定资产和投资性房地产折旧39,476,338.06-77,450,675.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧39,476,338.06-77,450,675.17-
  无形资产摊销17,147,117.78-9,292,031.96-
  长期待摊费用摊销1,643,528.22-3,057,288.71-
  处置固定资产、无形资产和其他长期资产的损失-520,388.61--1,089,285.1-
  固定资产报废损失133,968.03-149,021.93-
  公允价值变动损失986,558.98--10,518,654.06-
  财务费用2,272,731.63--2,657,230.34-
  投资损失-11,188,455.65--15,525,438.76-
  递延所得税-2,849,632.47--17,183,579.56-
  其中:递延所得税资产减少-2,234,525.8--15,229,440.73-
    递延所得税负债增加-615,106.67--1,954,138.83-
  存货的减少9,883,159.38--69,931,515.29-
  经营性应收项目的减少-295,679,594.77--20,453,213.95-
  经营性应付项目的增加160,568,867.1--69,589,297.06-
  其他11,318,637.72-35,366,329.25-
  现金的期末余额327,466,527.47-298,604,934.97-
  减:现金的期初余额298,604,934.97-258,783,949.74-
  现金及现金等价物的净增加额28,861,592.5-39,820,985.23-
公告日期2025-08-222025-04-292025-03-282024-10-25
审计意见(境内)标准无保留意见
TOP↑